Related Experiment Video

Updated: Jun 14, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Use of transcriptomics in understanding mechanisms of drug-induced toxicity

Yuxia Cui1, Richard S Paules

  • 1Environmental Stress & Cancer Group, National Institute of Environmental Health Sciences, Mail Drop D2-03, PO Box 12233, 111 TW Alexander Drive, Research Triangle Park, NC 27709, USA.

Pharmacogenomics
|March 31, 2010
PubMed

Insights

Toxicogenomics aids in understanding adverse drug reactions (ADRs) by revealing impacts on biological pathways. Transcriptomic studies offer mechanistic insights into drug-induced toxicity, particularly nephrotoxicity and hepatotoxicity.

Area of Science:

  • Pharmacology and Toxicology
  • Genomics and Molecular Biology

Background:

  • Adverse drug reactions (ADRs) pose significant clinical and public health challenges.
  • Understanding ADR mechanisms is crucial for diagnosis and management.
  • Toxicogenomics offers a powerful approach to uncover novel biological pathways involved in drug responses.

Purpose of the Study:

  • To review recent transcriptomic studies on drug-induced toxicity.
  • To highlight mechanistic insights into various ADRs, focusing on nephrotoxicity and hepatotoxicity.
  • To discuss related issues, including extrapolation of findings to humans and comparative systems biology.

Main Methods:

  • Review of recent transcriptomic studies.
  • Analysis of toxicogenomic data.
  • Discussion of comparative systems biology approaches.

Main Results:

  • Transcriptomic studies have provided valuable mechanistic insights into drug-induced toxicity.
  • Focus on nephrotoxicity and hepatotoxicity reveals specific pathways affected by drugs.
  • Extrapolation of findings from experimental models to humans using blood as a surrogate tissue is discussed.

Conclusions:

  • Toxicogenomics is essential for elucidating ADR mechanisms.
  • Transcriptomic data offers critical insights into drug-induced organ toxicities.
  • Systems biology approaches are vital for translating experimental findings to clinical applications.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Purification of Transcripts and Metabolites from Drosophila Heads12:49

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...